Methylsulfonylmethane Joint Pain Randomized Trial Evidence Table

Structured evidence table for Methylsulfonylmethane Joint Pain Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Methylsulfonylmethane Joint Pain Randomized TrialThere is a paucity of evidence regarding whether the effective outcomes of arthrocentesis in the management of temporomandibular joint disorders (TMJD) result from its use as a single treatment or in association with adjunctive therapy.1Simplot TM (2025)Controversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.
Methylsulfonylmethane Joint Pain Randomized TrialThe study aimed to compare arthrocentesis alone (ACA) and arthrocentesis (AC) associated with adjunctive therapy (AAAT) to determine the most effective treatment strategy.1Simplot TM (2025)Controversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.
topicMethylsulfonylmethane Joint Pain Randomized Trial
claimThere is a paucity of evidence regarding whether the effective outcomes of arthrocentesis in the management of temporomandibular joint disorders (TMJD) result from its use as a single treatment or in association with adjunctive therapy.
evidence level1
citationSimplot TM (2025)
sourceControversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.
topicMethylsulfonylmethane Joint Pain Randomized Trial
claimThe study aimed to compare arthrocentesis alone (ACA) and arthrocentesis (AC) associated with adjunctive therapy (AAAT) to determine the most effective treatment strategy.
evidence level1
citationSimplot TM (2025)
sourceControversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.

Source documents

  1. Controversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.